Change of auditor

RNS Number : 1827H

Intelligent Ultrasound Group PLC

02 December 2020

 

Intelligent Ultrasound Group plc

("the Company")

Change of Auditor

Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence ("AI") software and simulation company, announces that, following a competitive and comprehensive tender process, Deloitte LLP ("Deloitte") has been appointed as the Company's auditor for the year ending 31 December 2020. The Company intends to put the appointment of Deloitte as auditor to a vote of shareholders at the Company's next Annual General Meeting.

Following the tender process and the decision to appoint Deloitte, BDO LLP ("BDO") has resigned. The Board wishes to take this opportunity to extend appreciation and gratitude to BDO for its services rendered to the Company.

As required by section 519 of the Companies Act 2006, BDO has deposited a statement with the Company confirming that there are no circumstances in connection with its resignation as auditor that should be brought to the attention of the Company's shareholders and the reason for their resignation was as a result of the tender process.

For further information, please contact:

Intelligent Ultrasound Group plc			www. intelligentultrasound.com
Stuart Gall, CEO  Helen Jones, CFO			Tel: [phone]
Cenkos Securities - Nominated Advisor and Broker				Tel:  [phone]
Giles Balleny / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR	Tel: [phone] or  [e-mail]
Anna Dunphy / Paul McManus		Mob: [phone] / Mob: [phone]

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include  ScanNav Assist, which uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.

Products in development include ScanNav Anatomy PNB, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy  highlighting software for a range of medical procedures. ScanNav Anatomy has been submitted for CE and FDA regulatory approval.

Simulation Division 

Focusses on hi-fidelity ultrasound education and training through simulation.  Its three main products are the  ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date almost 1,000 simulators have been sold to over 600 medical institutions around the world.

www.intelligentultrasound.com

 

END

 

 

APPDZMGZVMFGGZM